ALISO VIEJO, Calif., Feb. 21, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that company management will participate in the Citi 2012 Global Health Care Conference. Citi 2012 Global Health Care Conference The Waldorf Astoria Hotel, New York, NY Wednesday, February 29, 2012 9:00 a.m. ET A live webcast and 30-day archive of this presentation will be available at http://ir.avanir.com. About Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com. AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc. ©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved. Avanir Investor & Media Contact Ian Clements, PhD firstname.lastname@example.org +1 (949) 389-6700 SOURCE Avanir Pharmaceuticals, Inc.